# Influence of Fampridine on Working Memory in Healthy Subjects

> **NCT04516603** · PHASE2 · WITHDRAWN · sponsor: **Prof. Dominique de Quervain, MD**

## Conditions studied

- Working Memory

## Interventions

- **DRUG:** Fampridine SR
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04516603
- **Lead sponsor:** Prof. Dominique de Quervain, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2040-01-01
- **Primary completion:** 2041-12-31
- **Final completion:** 2041-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Changement of study design. Restart spring 2021. See new registration number: NCT04652557 (FamH)
- **Last updated:** 2024-12-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04516603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04516603, "Influence of Fampridine on Working Memory in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04516603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*